Funding for Bedside-to-Bench Awards is provided in the following research categories by the entities listed below:

(1) AIDS: The NIH Office of AIDS Research will fund up to four exemplary AIDS-related projects.

(2) Behavioral and Social Sciences (OBSSR): The NIH Office of Behavioral and Social Sciences Research (OBSSR) will fund up to two projects that facilitate the translation of basic behavioral and social science research findings into effective interventions to prevent disease and to promote and optimize health. Of particular interest are interdisciplinary research and systems thinking and modeling approaches that integrate multiple levels of analysis - from cells to society - of factors that influence health. Key problems in population health where scientists, practitioners, and decision-makers can work together to accelerate the translation, implementation, dissemination, and adoption of behavioral and social sciences research findings are of high priority to OBSSR. The Office has strong interests in the development of behavioral interventions to improve health, studies of gene-environment interactions, adherence (at the patient and provider levels), measurement harmonization, primary care, mobile health, health disparities, shared medical decision-making, the exposome, and other areas. Additional information about OBSSR's strategic priorities can be found at http://obssr.od.nih.gov/about_obssr/strategic_planning/strategicPlanning.aspx.

(3) General: Additional meritorious projects will be considered in the 'general' category. Funding for projects in this category is restricted to intramural IC funding with potential funding support from the Office of Intramural Research. There are no funds to support extramural projects in the "general" category.

(4) Rare Diseases: The National Center for Advancing Translational Sciences will co-fund with institutes up to four projects. Projects must focus on an area of science/research directly related to a rare disease. An orphan or rare disease is generally considered to have a prevalence of less than 200,000 affected individuals in the United States. Certain diseases with more than 200,000 affected individuals are included but subpopulations of these conditions may be less than the prevalence standard for a rare disease. A comprehensive list of rare diseases, updated regularly, is available at http://rarediseases.info.nih.gov/RareDiseaseList.aspx?PageIC=1.

(5) Regenerative Medicine: The NIH Center for Regenerative Medicine will fund one project that supports efforts to accelerate the clinical translation of stem cell-based technologies, and to develop widely available resources to be used as standards in stem cell research. See mission of the NIH Center for Regenerative Medicine: http://crm.nih.gov/aboutCRM/index.asp.

(6) Women's Health (ORWH): The NIH Office of Research on Women's Health will fund one project that focuses on efforts to improve the health of women through biomedical and behavioral research on the roles of sex and gender in health and disease. Additional information about ORWH's strategic priorities can be found here: http://orwh.od.nih.gov/research/strategicplan/ORWH_StrategicPlan2020_Vol1.pdf (1.26 MB).

NOTE: PDF documents require the free Adobe Reader.